Expanding operations to provide specialty infusions can provide benefits to both patients and oncology practices.
Bob Zutaut, RPh
Advertisement
Bob Zutaut, RPh, is director of clinical services at McKesson.
Articles by Bob Zutaut, RPh
Pharmacists will have the opportunity to use their knowledge of biosimilars to reinforce their benefits, safety, and efficacy.
Advertisement
Latest Updated Articles
Offering Specialty Infusions May Be Worth the Work for Oncology PracticesPublished: November 7th 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer
2
Celebrating the Pharmacist’s Impact: How Pharmacists Elevate Care in Every Setting
3
FDA Approves 1-Minute HIV Self-Test
4
How Pharmacists Can Navigate Legal Complexities With Most Favored Nation Status
5
